M. Wang

Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study

J. Thorp, M. Clowse, R. Dolhain, 2017, Annals of the rheumatic diseases.

Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial

M. Lebwohl, A. Armstrong, K. Papp, 2021, The Lancet.

Systematic review and meta-analysis examining the relationship between postprandial hypotension, cardiovascular events, and all-cause mortality

C. Kendall, J. Sievenpiper, K. Srichaikul, 2022, American Journal of Clinical Nutrition.